Our findings indicated that CCDC8 was significantly downregulated in 17 tumor types, including bladder cancer (BLCA), and upregulated in only 2 cancer types, specifically head and neck squamous cell carcinoma (HNSC) and cholangiocarcinoma (CHOL) (Figure 1A). This evidence concerns the gene CCDC8 and urinary bladder carcinoma.